Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00659828 · ClinicalTrials.gov registry record · Phase 2
Effects of Leptin Replacement in Children
A Phase 2 study, sponsored by University of Miami.
- Completed
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT00659828 is a Phase 2 study that has completed, run by University of Miami. The registered enrollment target is 1 participants.
The verdict
NCT00659828, a Phase 2 study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
To assess the endocrine and immune effects of leptin replacement in leptin-deficient children, from a consanguineous family. The hypothesis is that leptin replacement will have significant effects on endocrine function.
Interventions
- DRUG Recombinant methionyl human leptin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2005-06 |
| Est. Completion | 2010-04-16 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00659828
The ClinicalTrials.gov registry entry for NCT00659828 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Recombinant methionyl human leptin is the first listed.
NCT00659828 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00659828 about?
NCT00659828 is a clinical study titled "Effects of Leptin Replacement in Children". To assess the endocrine and immune effects of leptin replacement in leptin-deficient children, from a consanguineous family. The hypothesis is that leptin replacement will have significant effects on endocrine function.
What is the current status of trial NCT00659828?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2005-06. Estimated completion is 2010-04-16.
What interventions are being tested in trial NCT00659828?
The interventions under investigation include: Recombinant methionyl human leptin (DRUG).
Who is sponsoring clinical trial NCT00659828?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.